[
    "{\"step_by_step_thinking\": \"Recombinant alpha-iduronidase is mentioned in several documents as a treatment for a specific disease. Document [0] mentions that recombinant human alpha L- iduronidase is used for patients with the Hurler and Hurler-Scheie forms of MPS I. Document [1] also mentions that recombinant alpha-L-iduronidase enzyme replacement therapy is a treatment strategy for mucopolysaccharidosis I patients, where Hurler and Scheie syndromes represent the two extremes. Therefore, it is clear that recombinant alpha-iduronidase is used for the treatment of Hurler syndrome.\", \"answer_choice\": \"C\"}"
]